Glac Biotech Co., Ltd. – Trademark Portfolio
Entity Type: 16
Glac Biotech Co., Ltd. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include PRONEX, TOTIPRO, PRONULIFE, and PAC TACTOPIA. The owner is based in Tainan City.
4F.-2, No. 17, Guoji Rd., Xinshi Dist.
Tainan City 744 , TW
Showing of trademarks Trademarks
Trademark Classifications
Glac Biotech Co., Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Glac Biotech Co., Ltd. have?
Glac Biotech Co., Ltd. has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 3 abandoned.
What trademark classes does Glac Biotech Co., Ltd. file in?
Glac Biotech Co., Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Glac Biotech Co., Ltd.'s most well-known trademarks?
Glac Biotech Co., Ltd.'s registered trademark portfolio includes well-known marks such as PRONEX, TOTIPRO, PRONULIFE, and PAC TACTOPIA. These are among 4 currently registered trademarks in the portfolio.
What is Glac Biotech Co., Ltd.'s trademark registration success rate?
Glac Biotech Co., Ltd. has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 1 application is pending review.